scholarly journals A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

2020 ◽  
Vol 190 (3) ◽  
Author(s):  
Walter Fiedler ◽  
Joerg Chromik ◽  
Stefanie Amberg ◽  
Maxim Kebenko ◽  
Felicitas Thol ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Acute Myeloid

Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study

2008 ◽  
Vol 87 (11) ◽  
pp. 881-885 ◽  
Author(s):  
Christophe Ravoet ◽  
Philippe Mineur ◽  
Valérie Robin ◽  
Louisette Debusscher ◽  
André Bosly ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myelodysplastic Syndrome ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Farnesyl Transferase ◽  
Farnesyl Transferase Inhibitor ◽  
Acute Myeloid

scholarly journals Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS

2015 ◽  
Vol 172 (2) ◽  
pp. 238-245 ◽  
Author(s):  
Raya Mawad ◽  
Pamela S. Becker ◽  
Paul Hendrie ◽  
Bart Scott ◽  
Brent L. Wood ◽  
...  
Keyword(s):  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Older Patients ◽  
Phase Ii Study ◽  
Newly Diagnosed ◽  
Acute Myeloid

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial

2009 ◽  
Vol 33 (8) ◽  
pp. 1124-1126 ◽  
Author(s):  
Patrice Chevallier ◽  
Mathilde Hunault-Berger ◽  
Fabrice Larosa ◽  
Charles Dauriac ◽  
Richard Garand ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
High Dose ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document